Увеит в практике ревматолога: роль ингибиторов фактора некроза опухоли а
Аннотация
Литература
1. <div><p>Gritz D., Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California epidemiology of uveitis study. Ophthalmology 2004;111:491-500.</p><p>Bodaghi B., Cassoux N., Wechsler B. et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) 2001;80:263-70.</p><p>Edmunds L., Elswood J., Calin A. New light on uveitis in ankylosing spondylitis. J Rheumatol 1991;18:50-2.</p><p>Banares A., Hernandez-Garcia C., Fernandez-Gutierrez B. et al. Eye involvement in the spondyloarthropathies. Rheum Dis Clin North Amer 1998;24:771-84.</p><p>Fernandez-Melon J., Munoz-Fernandez S., Hidalgo V. et al. Uveitis as the initial clinical manifestation in patients with spondy-loarthropathies. J Rheumatol 2004;31:524-7.</p><p>Bloch-Michel E., Nussenblatt R. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Amer J Ophthalmol 1987;103:234-5.</p><p>Bodaghi B., Cassoux N., Wechsler B. et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) 2001;80:263-70.</p><p>Dick A., Forrester J., Liversidge J. et al. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoreα tinitis (EAU). Prog Retin Eye Res 2004;23:617-37.</p><p>Xu H., Dawson R., Crane I. et al. Eukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood- retina barrier. Invest Ophthalmol Vis Sci 2005;46:2487-94.</p><p>Franks W., Limb G., Stanford M. et al. Cytokines in human intraocular inflammation. Curr Eye Res 1992;11:187-91.</p><p>Murphy C., Duncan L., Forrester J. et al. Systemic CD4-T cell phenotype and activation status in intermediate uveitis. Br J Ophthalmol 2004;88:412-6.</p><p>Torun N., Callizo J., Orlic N. et al. Serum cytokine receptor levels in noninfectious uveitis. Ophthalmic Res 2005;37:112-6.</p><p>Munoz-Fernandez S., Martin-Mola E. Uveitis.Best Practice & Research Clin Rheumatol 2006;20(3):487-505.</p><p>Bodaghi B., Cassoux N., Wechsler B. et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) 2001;80:263-70.</p><p>Braun J., Baraliakos X., Listing J. et al. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthr Rheum 2005;52(8):2447-51.</p><p>Rudwaleit М., R0devand E., Holck P. et al. Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis 2009;68:696-701.</p><p>El-Shabrawi Y., Hermann J. Anti-tumour necrosis factor alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27 associated acute anterior uveitis. Ophthalmology 2002;109:2342-6.</p><p>Sfikakis P., Theodossiadis P., Katsiari C. et al. Effect of infliximab on sight threatening panuveitis in Behcets disease. Lancet 2001;358:295-6.</p><p>Tugal-Tutkun I., Mudun A., Urgancioglu M. et al. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporin and corticosteroids in BehcetXs disease. Arthritis Rheum 2005;52:2478-84.</p><p>Yamada Y., Sugita S., Tanaka H. et al. Comparison of infliximab versus cyclosporine during the initial 6-month treatment period in Behcet's disease. Br J Ophthalmol 2009 Aug 18. [Epub ahead of print].</p><p>Murray P., Sivaraj R. Anti-TNF alpha therapy for uveitis: Behcet and beyond. Eye 2005;19:831-3.</p><p>Lindstedt E., Baarsma G., Kuijpers R. et al. Anti TNF alpha therapy for sight threatening uveitis. Br J Ophthalmol 2005;89:533-6.</p><p>Suhler E., Smith J., Wertheim M. et al. A prospective trial of infliximab therapy for refractory uveitis. Arch Ophthalmol 2005;123:903-12.</p><p>Benitez-del-Castillo J., Martinez-de-la-Casa J., Pato-Cour E. et al. Long-term treatment of refractory posterior uveitis with anti TNF alpha (Infliximab). Eye 2005;19:841 - 5.</p><p>Lopez-Gonzalez R., Loza E., Jover J. et al. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study. Scand J Rheumatol 2009;38(1):58-62.</p></div><br />
Рецензия
Для цитирования:
Моисеев С.В. Увеит в практике ревматолога: роль ингибиторов фактора некроза опухоли а. Современная ревматология. 2009;3(4):76-81. https://doi.org/10.14412/1996-7012-2009-577
For citation:
Moiseyev S.V. UVEITIS INA RHEUMATOLOGISTS PRACTICE: A ROLE OF TUMOR NECROSIS FACTOR-а INHIBITORS. Modern Rheumatology Journal. 2009;3(4):76-81. (In Russ.) https://doi.org/10.14412/1996-7012-2009-577